> Some US states have blocked pharmacies from filling doctor prescriptions for HCQ, instead of advocating for increased manufacturing capacity within US factori

> Some US states have blocked pharmacies from filling doctor prescriptions for HCQ, instead of advocating for increased manufacturing capacity within US factories that make HCQ/ingredients. This was done because of a run on HCQ by people who had no business prescribing it such as dentists and others who were abusing their prescribing authority. Meanwhile patients who have depended on HCQ for decades were facing withdrawal because the drug supply had suddenly choked up. > Meanwhile, we boosted ventilator production, where hospitals received $30K for each late-stage patient placed on ventilation, with only 20% chance of survival. The 20% chance of survival on a ventilator was a clickbait and has been proven false. https://www.npr.org/sections/health-shots/2020/05/15/856768020/new-evidence-suggests-covid-19-patients-on-ventilators-usually-survive https://www.npr.org/sections/health-shots/2020/05/15/8567680... > The mortality rate among 165 COVID-19 patients placed on a ventilator at Emory was just under 30%. And unlike the New York study, only a few patients were still on a ventilator when the data were collected. It’s almost the exact opposite - 70-80% of vented patients are surviving. Meanwhile HCQ/zinc therapy has not shown any benefit despite a rush across the world to try and use it.